NO308843B1 - Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler - Google Patents

Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler

Info

Publication number
NO308843B1
NO308843B1 NO973312A NO973312A NO308843B1 NO 308843 B1 NO308843 B1 NO 308843B1 NO 973312 A NO973312 A NO 973312A NO 973312 A NO973312 A NO 973312A NO 308843 B1 NO308843 B1 NO 308843B1
Authority
NO
Norway
Prior art keywords
levobupivacaine
anesthetics
preparation
carboxanilide
racemization process
Prior art date
Application number
NO973312A
Other languages
English (en)
Other versions
NO973312D0 (no
NO973312L (no
Inventor
Ulrich Conrad Dyer
Marianne Langston
Martin Woods
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO973312D0 publication Critical patent/NO973312D0/no
Publication of NO973312L publication Critical patent/NO973312L/no
Publication of NO308843B1 publication Critical patent/NO308843B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO973312A 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler NO308843B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation
PCT/GB1996/000067 WO1996022281A1 (en) 1995-01-18 1996-01-12 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents

Publications (3)

Publication Number Publication Date
NO973312D0 NO973312D0 (no) 1997-07-17
NO973312L NO973312L (no) 1997-07-17
NO308843B1 true NO308843B1 (no) 2000-11-06

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973312A NO308843B1 (no) 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler

Country Status (20)

Country Link
EP (1) EP0804417B1 (no)
JP (1) JP4015696B2 (no)
KR (1) KR100404390B1 (no)
CN (1) CN1172912C (no)
AT (1) ATE242214T1 (no)
AU (1) AU701221B2 (no)
BR (1) BR9606821A (no)
CA (1) CA2208522C (no)
DE (1) DE69628540T2 (no)
DK (1) DK0804417T3 (no)
ES (1) ES2201166T3 (no)
FI (1) FI117437B (no)
GB (1) GB9501071D0 (no)
HU (1) HU227426B1 (no)
MX (1) MX9705428A (no)
NO (1) NO308843B1 (no)
PL (1) PL184091B1 (no)
PT (1) PT804417E (no)
WO (1) WO1996022281A1 (no)
ZA (1) ZA96403B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
LT2767292T (lt) 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
WO2023158722A2 (en) * 2022-02-16 2023-08-24 Teva Pharmaceuticals International Gmbh Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
DE69628540D1 (de) 2003-07-10
JPH11501905A (ja) 1999-02-16
NO973312D0 (no) 1997-07-17
MX9705428A (es) 1997-11-29
ATE242214T1 (de) 2003-06-15
KR100404390B1 (ko) 2004-01-31
NO973312L (no) 1997-07-17
HUP9901418A3 (en) 2001-01-29
AU4394896A (en) 1996-08-07
KR19980701432A (ko) 1998-05-15
CN1168134A (zh) 1997-12-17
PT804417E (pt) 2003-09-30
BR9606821A (pt) 1997-12-23
HUP9901418A2 (hu) 1999-08-30
EP0804417A1 (en) 1997-11-05
GB9501071D0 (en) 1995-03-08
DE69628540T2 (de) 2004-01-08
FI973040A0 (fi) 1997-07-17
EP0804417B1 (en) 2003-06-04
CN1172912C (zh) 2004-10-27
DK0804417T3 (da) 2003-10-06
CA2208522A1 (en) 1996-07-25
PL321378A1 (en) 1997-12-08
FI117437B (fi) 2006-10-13
HU227426B1 (en) 2011-05-30
WO1996022281A1 (en) 1996-07-25
ZA96403B (en) 1997-01-20
AU701221B2 (en) 1999-01-21
FI973040A (fi) 1997-07-17
CA2208522C (en) 2007-03-13
PL184091B1 (pl) 2002-08-30
JP4015696B2 (ja) 2007-11-28
ES2201166T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
NO308843B1 (no) Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
AU3738597A (en) Molecular model for vla-4 inhibitors
RU93057733A (ru) Способ стереоселективного получения замещенных пиперидинов
NO314725B1 (no) N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt enfremgangsmåtefor fremstilling av et legemiddel
DE69535592D1 (de) Verbesserung der effektivität von arzneimitteln duren deuterierung
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
BR9809389A (pt) Tratamento de distúrbios do sistema nervoso central com modulados de receptores de estrogênio seletivos
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
NO982712D0 (no) FremgangsmÕter og mellomprodukter for fremstilling av 1-benzyl-4-((5,6-dimetoksy-1-indanon)-2-yl)metylpiperidin
ATE214695T1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
DE69710051D1 (de) Auflösungsverfahren von threo-methylphenidate
DE69624825D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
NO981444D0 (no) Akustisk transduser, hydrofon med slik transduser og fremgangsmåte for fremstilling av hydrofonen
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
DE59606057D1 (de) Verfahren zur herstellung von dihydroxypyrimidin-derivaten
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
NO20023386L (no) Pseudopolymorf av (-)-cis-2-(2-Klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-one
ATE212969T1 (de) Verfahren zur herstellung von 2-halogenindan-1- onen
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
AU7377296A (en) Method for treating hepatitis virus infection
ATE256689T1 (de) Verfahren zur herstellung von ascorbinsaüre-2- monophosphat salz

Legal Events

Date Code Title Description
MK1K Patent expired